Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-08-07

FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental indication to expand ZYRTEC HIVES (cetirizine hydrochloride) for the treatment of urticaria (hives). The product is manufactured…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYRTEC HIVES (cetirizine hydrochloride)

Snippet

SUPPL AP for ZYRTEC HIVES (CETIRIZINE HYDROCHLORIDE)